Edition:
United Kingdom

Bio Path Holdings Inc (BPTH.OQ)

BPTH.OQ on NASDAQ Stock Exchange Capital Market

1.77USD
15 Jun 2018
Change (% chg)

$0.02 (+1.14%)
Prev Close
$1.75
Open
$1.76
Day's High
$1.77
Day's Low
$1.71
Volume
1,800
Avg. Vol
42,819
52-wk High
$5.85
52-wk Low
$1.53

Chart for

About

Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Its drug delivery and antisense technology, DNAbilize,... (more)
No analyst recommendations are available for .

Overall

Beta: 3.13
Market Cap(Mil.): $38.52
Shares Outstanding(Mil.): 100.06
Dividend: --
Yield (%): --

Financials

  BPTH.OQ Industry Sector
P/E (TTM): -- 84.11 32.75
EPS (TTM): -0.07 -- --
ROI: -70.12 1.56 14.38
ROE: -83.80 2.43 16.07

BRIEF-Bio-Path Holdings Reports Full Year 2017 Financial Results

* PATH HOLDINGS REPORTS FULL YEAR 2017 FINANCIAL RESULTS Source text for Eikon: Further company coverage:

03 Apr 2018

BRIEF-Bio Path Holdings Says Board Increased Its Size From Four Members To Five Members

* BIO PATH HOLDINGS INC SAYS ON FEB 1, 2018, BOARD OF CO, INCREASED ITS SIZE FROM FOUR MEMBERS TO FIVE MEMBERS - SEC FILING Source text: [http://bit.ly/2GQ9Xup] Further company coverage:

05 Feb 2018

BRIEF-Bio Path Holdings Provides Clinical Update And 2018 Business Outlook

* BIO-PATH HOLDINGS PROVIDES CLINICAL UPDATE AND 2018 BUSINESS OUTLOOK

29 Dec 2017

Earnings vs. Estimates